| Sep 15, 2010
There has never been a magic prescription to help millions of obese Americans lose weight. Whether one is any closer to reality is now under scrutiny.
A Food and Drug Administration advisory panel will decide Wednesday whether the diet drug Meridia...
| Jun 17, 2010
A pink pill designed to boost sex drive in women - the latest attempt by the drug industry to find a female equivalent to Viagra - fell short in two studies, federal health regulators said Wednesday.
The Food and Drug Administration is considering...
| Jul 15, 2010
Faced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...
| Aug 9, 2010
As the world's most-prescribed class of medications, statins indisputably qualify for the commercial distinction of "blockbuster." About 24 million Americans take the drugs — marketed under such commercial names as Pravachol, Mevacor, Lipitor, Zocor...
| Apr 13, 2009
About a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify "might be right for them." Few appeared to be delusional, plagued by hallucinations or suffering fearsome...
| Jan 8, 2011
Although first approved to treat schizophrenia, new antipsychotic medications are increasingly being prescribed for a host of other uses, even when there is little evidence they work, U.S. researchers said on Friday.
The drugs, known as "atypical...
| Mar 12, 2010
The Food and Drug Administration said Friday that it will require a new black-box warning on the label of the popular anti-clotting drug Plavix to indicate that some patients do not metabolize the drug properly and may receive little benefit......